Donor exposures in recipients of pooled platelet concentrates

New England Journal of Medicine

Volumn 368, Issue 5, 2013, Pages 487-489

  Thiele, Thomas ^a   Heddle, Nancy ^b   Greinacher, Andreas ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE CONCENTRATE;

ALLOIMMUNIZATION; APHERESIS; BLOOD BUFFY COAT; BLOOD DONOR; BLOOD GROUP AB; ERYTHROCYTE CONCENTRATE; EXPOSURE; HUMAN; LETTER; PLASMAPHERESIS; PRIORITY JOURNAL; RECIPIENT; THROMBOCYTE RICH PLASMA; THROMBOCYTE TRANSFUSION;

EID: 84873023465     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1213383     Document Type: Letter

References (2)

1. Lopez-Plaza I, Weissfeld J, Triulzi DJ. The cost-effectiveness of reducing donor exposures with single-donor versus pooled random-donor platelets. Transfusion 1999;39:925-32.
2. Vamvakas EC. Relative safety of pooled whole blood-derived versus single-donor (apheresis) platelets in the United States: a systematic review of disparate risks. Transfusion 2009;49:2743-58.